-
RAPT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
RAPT Therapeutics (RAPT)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 37.90 mm | 37.90 mm | 37.90 mm | 37.90 mm | 37.90 mm | |
Cash burn (monthly) | 2.47 mm | 1.02 mm | 6.60 mm | 9.95 mm | 6.39 mm | |
Cash used (since last report) | 6.96 mm | 2.88 mm | 18.57 mm | 28.03 mm | 18.00 mm | |
Cash remaining | 30.94 mm | 35.02 mm | 19.33 mm | 9.87 mm | 19.90 mm | |
Runway (months of cash) | 12.5 | 34.3 | 2.9 | 1.0 | 3.1 |
13F holders | Current |
---|---|
Total holders | 111 |
Opened positions | 38 |
Closed positions | 32 |
Increased positions | 26 |
Reduced positions | 25 |
13F shares | Current |
---|---|
Total value | 94.53 bn |
Total shares | 35.26 mm |
Total puts | 591.90 k |
Total calls | 904.90 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
FMR | 5.24 mm | $15.97 bn |
Vanguard | 3.11 mm | $9.48 bn |
Column | 2.68 mm | $8.18 bn |
BLK BlackRock | 2.44 mm | $7.44 bn |
Kingdon Capital Management, L.L.C. | 1.73 mm | $5.26 bn |
Column Group Ii | 1.60 mm | $17.72 mm |
Kleiner Perkins Caufield & Byers XV | 1.30 mm | $47.64 mm |
MS Morgan Stanley | 1.18 mm | $3.60 bn |
Millennium Management | 1.02 mm | $3.12 bn |
Deutsche Bank AG - Registered Shares | 932.54 k | $2.84 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Dec 24 | Column Group Ii | Common Stock | Other | Dispose J | Yes | No | 0 | 1,599,417 | 0.00 | 0 |
23 Dec 24 | Column Group Ii | Common Stock | Other | Dispose J | No | No | 0 | 1,352,008 | 0.00 | 50,000 |
23 Dec 24 | Column Group Ii | Warrant (right to purchase) Common Stock | Other | Acquire J | Yes | No | 0.0001 | 1,599,417 | 159.94 | 1,599,417 |
23 Dec 24 | Column Group Ii | Warrant (right to purchase) Common Stock | Other | Acquire J | No | No | 0.0001 | 1,352,008 | 135.20 | 1,352,008 |
23 Dec 24 | Column Group Ii | Common Stock | Other | Dispose J | Yes | No | 0 | 1,599,417 | 0.00 | 0 |
23 Dec 24 | Column Group Ii | Common Stock | Other | Dispose J | No | No | 0 | 1,352,008 | 0.00 | 50,000 |
23 Dec 24 | Column Group Ii | Warrant (right to purchase) Common Stock | Other | Acquire J | Yes | No | 0.0001 | 1,599,417 | 159.94 | 1,599,417 |
23 Dec 24 | Column Group Ii | Warrant (right to purchase) Common Stock | Other | Acquire J | No | No | 0.0001 | 1,352,008 | 135.20 | 1,352,008 |
13 Nov 24 | Rodney KB Young | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.57 | 90,000 | 141.30 k | 90,000 |
13 Nov 24 | Rodney KB Young | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 24.75 | 90,000 | 2.23 mm | 0 |